Single-cell RNA sequencing in osteosarcoma: applications in diagnosis, prognosis, and treatment

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Medical Oncology

• Publication date

  2025-11-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12032-025-03121-5PMID 41231422
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Integrated analysis of single-cell and bulk RNA sequencing data reveals a cellular senescence-related signature in hepatocellular carcinoma

  2024cited by this paper
• Single-cell and spatial transcriptomics reveal metastasis mechanism and microenvironment remodeling of lymph node in osteosarcoma

  2024cited by this paper
• Comparative investigation of neoadjuvant immunotherapy versus adjuvant immunotherapy in perioperative patients with cancer: a global-scale, cross-sectional, and large-sample informatics study

  2024cited by this paper
• The emerging role of microRNA-based therapeutics in the treatment of preeclampsia.

  2024cited by this paper
• Integrated analysis of single-cell and bulk RNA sequencing data reveals prognostic characteristics of lysosome-dependent cell death-related genes in osteosarcoma

  2024cited by this paper
• Single-cell RNA-seq reveals T cell exhaustion and immune response landscape in osteosarcoma

  2024cited by this paper
• What role does GPR65 play in the progression of osteosarcoma? Its mechanism and clinical significance

  2024cited by this paper
• Single‐cell RNA sequencing reveals SERPINE1‐expressing CAFs remodelling tumour microenvironment in recurrent osteosarcoma

  2024cited by this paper
• Advancing pharmaceutical research: A comprehensive review of cutting-edge tools and technologies

  2024cited by this paper
• Spatial multiplexed immunofluorescence analysis reveals coordinated cellular networks associated with overall survival in metastatic osteosarcoma

  2024cited by this paper
• A useful mTORC1 signaling-related RiskScore model for the personalized treatment of osteosarcoma patients by using the bulk RNA-seq analysis

  2024cited by this paper
• Advances on immunotherapy for osteosarcoma

  2024cited by this paper
• Whole genome and reverse protein phase array landscapes of patient derived osteosarcoma xenograft models

  2024cited by this paper
• A single-cell and spatially resolved atlas of human osteosarcomas

  2024cited by this paper
• Advances in drug discovery based on network pharmacology and omics technology

  2024cited by this paper
• Integration of single-cell sequencing and bulk expression data reveals chemokine signaling pathway in proliferating cells is associated with the survival outcome of osteosarcoma

  2023cited by this paper
• European Society of Toxicologic Pathology (Pathology 2.0 Molecular Pathology Special Interest Group): Review of In Situ Hybridization Techniques for Drug Research and Development

  2023cited by this paper
• Analysis of intercellular communication in the osteosarcoma microenvironment based on single cell sequencing data

  2023cited by this paper
• Integrated multiomic analysis and high‐throughput screening reveal potential gene targets and synergetic drug combinations for osteosarcoma therapy

  2023cited by this paper
• A new insight of immunosuppressive microenvironment in osteosarcoma lung metastasis

  2023cited by this paper
• An Exploration of Osteosarcoma Metastasis Diagnostic Markers Based on Tumor-Associated Neutrophils.

  2023cited by this paper
• TYROBP-positive endothelial cell-derived TWEAK as a promoter of osteosarcoma progression: insights from single-cell omics

  2023cited by this paper
• RNA-seq and Single-Cell Transcriptome Analyses of TRAIL Receptors Gene Expression in Human Osteosarcoma Cells and Tissues

  2023cited by this paper
• Comprehensive multi-omics analysis reveals m7G-related signature for evaluating prognosis and immunotherapy efficacy in osteosarcoma

  2023cited by this paper
• Genome-wide identification of alternative splicing and splicing regulated in immune infiltration in osteosarcoma patients

  2023cited by this paper
• AlphaFold2 and its applications in the fields of biology and medicine

  2023cited by this paper
• Modelling capture efficiency of single-cell RNA-sequencing data improves inference of transcriptome-wide burst kinetics

  2023cited by this paper
• Studying the mechanism underlying lipid metabolism in osteosarcoma based on transcriptomic RNA sequencing and single‐cell data

  2023cited by this paper
• High GNG4 predicts adverse prognosis for osteosarcoma: Bioinformatics prediction and experimental verification

  2023cited by this paper
• Abnormal signal pathways and tumor heterogeneity in osteosarcoma

  2023cited by this paper
• Single-cell RNA datasets and bulk RNA datasets analysis demonstrated C1Q+ tumor-associated macrophage as a major and antitumor immune cell population in osteosarcoma

  2023cited by this paper
• Advances and Challenges in Spatial Transcriptomics for Developmental Biology

  2023cited by this paper
• Single-cell and spatial sequencing application in pathology

  2023cited by this paper
• Cellular Transcriptomics of Carboplatin Resistance in a Metastatic Canine Osteosarcoma Cell Line

  2023cited by this paper
• Characterizing the tumor microenvironment at the single-cell level reveals a novel immune evasion mechanism in osteosarcoma

  2023cited by this paper
• A review of computational methods for predicting cancer drug response at the single-cell level through integration with bulk RNAseq data.

  2023cited by this paper
• Expression of PD-1 mitigates phagocytic activities TAM in osteosarcoma

  2023cited by this paper
• Osteoclasts in Osteosarcoma: Mechanisms, Interactions, and Therapeutic Prospects

  2023cited by this paper
• Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis

  2023cited by this paper
• Network pharmacology and experimental verification-based strategy for exploring the mechanisms of luteolin in the treatment of osteosarcoma

  2023cited by this paper
• A novel molecular classification method for osteosarcoma based on tumor cell differentiation trajectories

  2023cited by this paper
• The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring

  2023cited by this paper
• Host-derived growth factors drive ERK phosphorylation and MCL1 expression to promote osteosarcoma cell survival during metastatic lung colonization

  2023cited by this paper
• Deciphering the heterogeneity and immunosuppressive function of regulatory T cells in osteosarcoma using single-cell RNA transcriptome

  2023cited by this paper
• Carboxypeptidase E is a prognostic biomarker co-expressed with osteoblastic genes in osteosarcoma

  2023cited by this paper
• Single-cell RNA sequencing reveals small extracellular vesicles derived from malignant cells that contribute to angiogenesis in human breast cancers

  2023cited by this paper
• Advances in single-cell RNA sequencing and its applications in cancer research

  2023cited by this paper
• The Targeted Therapies for Osteosarcoma via Six Major Pathways.

  2023cited by this paper
• Single-cell transcriptomics reveals the regulative roles of cancer associated fibroblasts in tumor immune microenvironment of recurrent osteosarcoma

  2022cited by this paper
• Innovative approaches for treatment of osteosarcoma

  2022cited by this paper
• Circulating tumour cells in the -omics era: how far are we from achieving the ‘singularity’?

  2022cited by this paper
• Single-cell RNA-seq identification of four differentially expressed survival-related genes by a TARGET: Osteosarcoma database analysis

  2022cited by this paper
• Osteoclasts differential-related prognostic biomarker for osteosarcoma based on single cell, bulk cell and gene expression datasets

  2022cited by this paper
• Single‐cell RNA sequencing technologies and applications: A brief overview

  2022cited by this paper
• Targeting signaling pathway by curcumin in osteosarcoma.

  2022cited by this paper
• Clinicopathological value of the upregulation of cyclin-dependent kinases regulatory subunit 2 in osteosarcoma

  2022cited by this paper
• Identification of Cell Subpopulations and Interactive Signaling Pathways From a Single-Cell RNA Sequencing Dataset in Osteosarcoma: A Comprehensive Bioinformatics Analysis

  2022cited by this paper
• Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications

  2022cited by this paper
• Single-cell RNA sequencing reveals differential expression of EGFL7 and VEGF in giant-cell tumor of bone and osteosarcoma

  2022cited by this paper
• The Role of NR4A1 in the Pathophysiology of Osteosarcoma: A Comprehensive Bioinformatics Analysis of the Single-Cell RNA Sequencing Dataset

  2022cited by this paper
• Therapeutic nature of microRNAs in Oral Squamous Cell Carcinoma (OSCC).

  2022cited by this paper
• Ewing sarcoma and osteosarcoma have distinct immune signatures and intercellular communication networks.

  2022cited by this paper
• Comprehensive analysis of potential cellular communication networks in advanced osteosarcoma using single-cell RNA sequencing data

  2022cited by this paper
• Characterization of the tumour microenvironment phenotypes in malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients

  2022cited by this paper
• Single-Cell Transcriptome Analysis Reveals Paraspeckles Expression in Osteosarcoma Tissues

  2022cited by this paper
• Osteosarcoma tumors maintain intra-tumoral transcriptional heterogeneity during bone and lung colonization

  2022cited by this paper
• Infiltration of LPAR5+ macrophages in osteosarcoma tumor microenvironment predicts better outcomes

  2022cited by this paper
• Analysis of scRNA-seq and bulk RNA-seq demonstrates the effects of EVI2B or CD361 on CD8+ T cells in osteosarcoma

  2022cited by this paper
• Single‐cell next‐generation sequencing of circulating tumor cells in patients with neuroblastoma

  2022cited by this paper
• Identification of novel prognostic biomarkers for osteosarcoma: a bioinformatics analysis of differentially expressed genes in the mesenchymal stem cells from single-cell sequencing data set

  2022cited by this paper
• Prime-seq, efficient and powerful bulk RNA sequencing

  2021cited by this paper
• Clinical Perspectives of Single-Cell RNA Sequencing

  2021cited by this paper
• Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study.

  2021cited by this paper
• Single-Cell Transcriptomics Reveals the Complexity of the Tumor Microenvironment of Treatment-Naive Osteosarcoma

  2021cited by this paper
• A plate-based single-cell ATAC-seq workflow for fast and robust profiling of chromatin accessibility

  2021cited by this paper
• Highly accurate protein structure prediction with AlphaFold

  2021cited by this paper
• Applications of single-cell sequencing in cancer research: progress and perspectives

  2021cited by this paper
• Applications of Single-Cell Omics in Tumor Immunology

  2021cited by this paper
• Single-cell RNA sequencing in cancer: Applications, advances, and emerging challenges

  2021cited by this paper
• Advances in bulk and single-cell multi-omics approaches for systems biology and precision medicine.

  2021cited by this paper
• Mechanisms of Resistance to Conventional Therapies for Osteosarcoma

  2021cited by this paper
• Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma

  2020cited by this paper
• Efficacy and safety of oral metronomic etoposide in adult patients with metastatic osteosarcoma

  2020cited by this paper
• Implications of microRNA 21 and its involvement in the treatment of different type of arthritis

  2020cited by this paper
• Artificial intelligence in drug discovery and development

  2020cited by this paper
• Bone Microenvironment and Osteosarcoma Metastasis

  2020cited by this paper
• Nanoparticle enhanced combination therapy for stem-like progenitors defined by single-cell transcriptomics in chemotherapy-resistant osteosarcoma

  2020cited by this paper
• Statistical and Bioinformatics Analysis of Data from Bulk and Single-Cell RNA Sequencing Experiments.

  2020cited by this paper
• Molecular Biology of Osteosarcoma

  2020cited by this paper
• Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects

  2020cited by this paper
• The Osteosarcoma Microenvironment: A Complex but Targetable Ecosystem

  2020cited by this paper
• The CD24+ cell subset promotes invasion and metastasis in human osteosarcoma

  2020cited by this paper
• Luteolin, a flavonoid, as an anticancer agent: A review.

  2019cited by this paper
• Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study.

  2019cited by this paper
• Single-Cell RNA-Seq Technologies and Related Computational Data Analysis

  2019cited by this paper
• PyMINEr Finds Gene and Autocrine-Paracrine Networks from Human Islet scRNA-Seq

  2019cited by this paper
• Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication

  2019cited by this paper
• Profiling Tumor Infiltrating Immune Cells with CIBERSORT.

  2018cited by this paper
• Introduction to Single‐Cell RNA Sequencing

  2018cited by this paper
• Missing data and technical variability in single‐cell RNA‐sequencing experiments

  2018cited by this paper

• Advances in the identification of novel cell signatures in benign prostatic hyperplasia and prostate cancer using single-cell RNA sequencing

  2026cites this paper